loading
Zimmer Biomet Holdings Inc stock is traded at $100.02, with a volume of 1.84M. It is up +0.77% in the last 24 hours and up +6.64% over the past month. Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
See More
Previous Close:
$99.26
Open:
$99.54
24h Volume:
1.84M
Relative Volume:
0.87
Market Cap:
$19.81B
Revenue:
$7.68B
Net Income/Loss:
$903.80M
P/E Ratio:
22.48
EPS:
4.45
Net Cash Flow:
$1.14B
1W Performance:
+8.25%
1M Performance:
+6.64%
6M Performance:
+1.05%
1Y Performance:
-7.46%
1-Day Range:
Value
$98.78
$100.57
1-Week Range:
Value
$90.67
$101.93
52-Week Range:
Value
$89.24
$116.71

Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile

Name
Name
Zimmer Biomet Holdings Inc
Name
Phone
(574) 267-6131
Name
Address
345 EAST MAIN STREET, WARSAW, IN
Name
Employee
17,000
Name
Twitter
@zimmerbiomet
Name
Next Earnings Date
2024-10-30
Name
Latest SEC Filings
Name
ZBH's Discussions on Twitter

Compare ZBH with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
ZBH
Zimmer Biomet Holdings Inc
100.02 19.66B 7.68B 903.80M 1.14B 4.45
Medical Devices icon
ABT
Abbott Laboratories
131.36 233.71B 43.11B 13.98B 6.78B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
102.75 152.83B 18.49B 2.51B 3.23B 1.68
Medical Devices icon
SYK
Stryker Corp
376.67 144.35B 23.82B 2.92B 4.02B 7.55
Medical Devices icon
MDT
Medtronic Plc
92.74 119.00B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
78.16 46.00B 5.69B 4.14B 577.90M 6.96

Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-15-25 Upgrade Roth Capital Neutral → Buy
Dec-17-24 Upgrade JP Morgan Neutral → Overweight
Sep-10-24 Initiated Wolfe Research Peer Perform
Jul-01-24 Downgrade Piper Sandler Overweight → Neutral
May-30-24 Initiated Goldman Neutral
May-21-24 Upgrade Argus Hold → Buy
Jan-04-24 Downgrade Evercore ISI Outperform → In-line
Oct-20-23 Initiated ROTH MKM Neutral
Aug-28-23 Upgrade BTIG Research Neutral → Buy
May-03-23 Upgrade BofA Securities Underperform → Neutral
Apr-11-23 Upgrade Evercore ISI In-line → Outperform
Mar-31-23 Upgrade Jefferies Underperform → Hold
Mar-29-23 Initiated UBS Sell
Mar-10-23 Upgrade Piper Sandler Neutral → Overweight
Jan-09-23 Upgrade RBC Capital Mkts Sector Perform → Outperform
Jan-05-23 Upgrade Raymond James Mkt Perform → Outperform
Jan-03-23 Downgrade Evercore ISI Outperform → In-line
Nov-23-22 Upgrade Wells Fargo Underweight → Equal Weight
Oct-18-22 Initiated Barclays Underweight
Oct-12-22 Initiated Jefferies Underperform
May-27-22 Downgrade Needham Buy → Hold
Apr-13-22 Downgrade Truist Buy → Hold
Apr-01-22 Downgrade Citigroup Buy → Neutral
Mar-02-22 Resumed BofA Securities Underperform
Mar-02-22 Downgrade Loop Capital Buy → Hold
Feb-08-22 Downgrade Canaccord Genuity Buy → Hold
Feb-08-22 Reiterated Citigroup Buy
Feb-08-22 Reiterated Deutsche Bank Hold
Feb-08-22 Reiterated JMP Securities Mkt Outperform
Feb-08-22 Reiterated JP Morgan Neutral
Feb-08-22 Reiterated RBC Capital Mkts Sector Perform
Feb-08-22 Reiterated Stifel Buy
Feb-08-22 Reiterated Truist Buy
Feb-08-22 Reiterated UBS Neutral
Feb-08-22 Reiterated Wells Fargo Underweight
Feb-02-22 Downgrade UBS Buy → Neutral
Jan-19-22 Downgrade Wells Fargo Equal Weight → Underweight
Jan-10-22 Downgrade Mizuho Buy → Neutral
Jan-07-22 Downgrade Morgan Stanley Overweight → Equal-Weight
Jan-04-22 Downgrade Piper Sandler Overweight → Neutral
Dec-10-21 Initiated RBC Capital Mkts Sector Perform
Dec-09-21 Downgrade Needham Strong Buy → Buy
Dec-07-21 Initiated Loop Capital Buy
Nov-23-21 Downgrade Argus Buy → Hold
Sep-14-21 Resumed Raymond James Mkt Perform
May-25-21 Initiated Barclays Overweight
Apr-09-21 Upgrade Northland Capital Market Perform → Outperform
Jan-04-21 Upgrade Evercore ISI In-line → Outperform
Dec-18-20 Reiterated Needham Strong Buy
Oct-20-20 Initiated Northland Capital Market Perform
Sep-11-20 Initiated Wolfe Research Outperform
Aug-05-20 Reiterated Needham Strong Buy
Apr-28-20 Downgrade Guggenheim Buy → Neutral
Apr-09-20 Downgrade Evercore ISI Outperform → In-line
Apr-07-20 Reiterated Needham Strong Buy
Mar-05-20 Initiated Citigroup Buy
Feb-13-20 Initiated Goldman Buy
Jan-08-20 Initiated SunTrust Buy
Jan-07-20 Upgrade Piper Jaffray Neutral → Overweight
Jan-07-20 Upgrade Piper Sandler Neutral → Overweight
Dec-04-19 Upgrade Raymond James Outperform → Strong Buy
Oct-07-19 Upgrade BTIG Research Neutral → Buy
Sep-18-19 Upgrade Canaccord Genuity Hold → Buy
Aug-12-19 Upgrade Argus Hold → Buy
Jul-30-19 Upgrade Barclays Underweight → Equal Weight
Jul-29-19 Upgrade Robert W. Baird Neutral → Outperform
Jun-11-19 Upgrade Bernstein Underperform → Mkt Perform
Apr-24-19 Upgrade Needham Buy → Strong Buy
View All

Zimmer Biomet Holdings Inc Stock (ZBH) Latest News

pulisher
Aug 11, 2025

Needham Maintains a Neutral Stance on Zimmer Biomet Holdings (ZBH) - MSN

Aug 11, 2025
pulisher
Aug 11, 2025

Zimmer (ZBH) Builds Robotics Growth Pipeline, but BofA Sees Limited Near-Term Upside - MSN

Aug 11, 2025
pulisher
Aug 11, 2025

Zimmer Biomet (ZBH) Jumps After Raising 2025 Outlook on Strong Hip and Knee Sales—Is Momentum Sustainable? - simplywall.st

Aug 11, 2025
pulisher
Aug 10, 2025

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q2 2025 Earnings Call Transcript - MSN

Aug 10, 2025
pulisher
Aug 10, 2025

Healthcare Sector Analysts Weigh In on Sangamo Biosciences, Pliant Therapeutics, and Zimmer Biomet Holdings - AInvest

Aug 10, 2025
pulisher
Aug 10, 2025

What You Need To Know Ahead of Zimmer Biomet's Earnings Release - MSN

Aug 10, 2025
pulisher
Aug 10, 2025

Zimmer Biomet Acquires Monogram Technologies, Boosting Robotics Growth Pipeline, but BofA Sees Limited Near-Term Upside - AInvest

Aug 10, 2025
pulisher
Aug 09, 2025

While shareholders of Zimmer Biomet Holdings (NYSE:ZBH) are in the red over the last five years, underlying earnings have actually grown - simplywall.st

Aug 09, 2025
pulisher
Aug 09, 2025

Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MSN

Aug 09, 2025
pulisher
Aug 09, 2025

Zimmer Biomet Holdings Maintains Hold Rating Amid Volatility Concerns - AInvest

Aug 09, 2025
pulisher
Aug 08, 2025

Zimmer Biomet Surges Despite 404th-Ranked Liquidity as Earnings Outperform and UBS Maintains Sell Rating - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

RBC Capital Raises Zimmer Biomet PT to $115, Maintains Outperform Rating - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

UBS maintains Sell rating, raises Zimmer Biomet PT to $96 from $91. - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Morgan Stanley Raises Price Target on Zimmer Biomet to $100 From $95 - MarketScreener

Aug 08, 2025
pulisher
Aug 08, 2025

Raymond James maintains Outperform rating on Zimmer Biomet with new PT of $113. - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Zimmer Biomet Holdings, Inc. shares fall 1.09% intraday as brokerages adjust price targets and global growth concerns persist. - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

RBC Raises Price Target on Zimmer Biomet Holdings to $115 From $112, Keeps Outperform Rating - MarketScreener

Aug 08, 2025
pulisher
Aug 08, 2025

Zimmer Biomet price target raised to $113 from $104 at Raymond James - TipRanks

Aug 08, 2025
pulisher
Aug 08, 2025

UBS Hikes Price Target on Zimmer Biomet to $96 From $91, Maintains Sell Rating - MarketScreener

Aug 08, 2025
pulisher
Aug 08, 2025

Bernstein raises Zimmer Biomet stock price target to $105 on improving outlook - Investing.com Canada

Aug 08, 2025
pulisher
Aug 08, 2025

Zimmer Biomet Boosts 2025 Outlook on Strong Portfolio Growth and Reduced Tariff Impacts - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Zimmer Biomet price target raised to $96 from $91 at UBS - TipRanks

Aug 08, 2025
pulisher
Aug 08, 2025

Zimmer Biomet raises 2025 outlook amid strong portfolio growth - Yahoo Finance

Aug 08, 2025
pulisher
Aug 08, 2025

Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum? - Yahoo Finance

Aug 08, 2025
pulisher
Aug 08, 2025

Zimmer Biomet Holdings: Balancing Strong Segment Growth with US Knee Challenges – Hold Rating Maintained - TipRanks

Aug 08, 2025
pulisher
Aug 08, 2025

Zimmer Biomet Q2 2025 net sales up 7% to USD 2.077B - Medical Buyer

Aug 08, 2025
pulisher
Aug 08, 2025

Jefferies Adjusts Price Target on Zimmer Biomet to $110 From $103, Maintains Hold Rating - MarketScreener

Aug 08, 2025
pulisher
Aug 08, 2025

Bernstein Adjusts Price Target on Zimmer Biomet to $105 From $100, Maintains Market Perform Rating - MarketScreener

Aug 08, 2025
pulisher
Aug 08, 2025

JPMorgan Adjusts Price Target on Zimmer Biomet to $115 From $105, Maintains Overweight Rating - MarketScreener

Aug 08, 2025
pulisher
Aug 08, 2025

Spinal Fusion Devices Market Outlook Report 2025-2029: Revenues to Grow by $2.9 Billion Driven by Rising Spinal Disorders, Technological Advances, and Increasing Device Launches - GlobeNewswire Inc.

Aug 08, 2025
pulisher
Aug 08, 2025

Zimmer: Q2 Earnings Snapshot - Connecticut Post

Aug 08, 2025
pulisher
Aug 08, 2025

Zimmer Biomet Reports Strong Q2 2025 Results - TipRanks

Aug 08, 2025
pulisher
Aug 07, 2025

Zimmer Biomet Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 07, 2025
pulisher
Aug 07, 2025

Zimmer Biomet Surges 7.99% on Revised Earnings and Tariff Relief Ranks 287th in $420M Volume - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Zimmer Biomet Reports Q2 Earnings, Raises Full-Year Outlook - InkFreeNews.com

Aug 07, 2025
pulisher
Aug 07, 2025

Zimmer Biomet Holdings: Hold Rating Maintained Amid Stable Growth and Second-Half Optimism - TipRanks

Aug 07, 2025
pulisher
Aug 07, 2025

Zimmer Biomet raises annual profit forecast on strong demand for medical devices - WKZO

Aug 07, 2025
pulisher
Aug 07, 2025

Zimmer Biomet Holdings: Hold Rating Maintained Amid Modest Growth and Market Shifts - TipRanks

Aug 07, 2025
pulisher
Aug 07, 2025

Zimmer Biomet price target raised to $138 from $135 at Roth Capital - TipRanks

Aug 07, 2025
pulisher
Aug 07, 2025

Zimmer Biomet Exceeds Q2 Expectations with 7% YoY Revenue Growth - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Zimmer Biomet (NYSE:ZBH) Exceeds Q2 Expectations, Stock Soars - Yahoo Finance

Aug 07, 2025
pulisher
Aug 07, 2025

Zimmer Biomet raises annual profit forecast on lower tariff impact - MSN

Aug 07, 2025
pulisher
Aug 07, 2025

ZBH Stock Gains On Q2 Earnings and Revenue Beat, '25 EPS View Up - The Globe and Mail

Aug 07, 2025
pulisher
Aug 07, 2025

Zimmer Biomet Flexes Strong Q2, Raises 2025 OutlookZimmer Biomet Holdings (NYSE:ZBH) - Benzinga

Aug 07, 2025
pulisher
Aug 07, 2025

Zimmer Biomet posts Q2 beats, raises EPS guidance - MassDevice

Aug 07, 2025
pulisher
Aug 07, 2025

Transcript : Zimmer Biomet Holdings, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener

Aug 07, 2025
pulisher
Aug 07, 2025

Zimmer Biomet Holdings Shares Surge Amid Strong Q2 - TipRanks

Aug 07, 2025
pulisher
Aug 07, 2025

Zimmer (ZBH) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo Finance

Aug 07, 2025
pulisher
Aug 07, 2025

Zimmer Biomet Lifts Forecast As Joint Implant Sales Climb - Finimize

Aug 07, 2025
pulisher
Aug 07, 2025

Zimmer Biomet (ZBH) Beats Q2 Earnings and Revenue Estimates - sg.finance.yahoo.com

Aug 07, 2025
pulisher
Aug 07, 2025

Zimmer Biomet Holdings, Inc. Revises Earnings Guidance for the Full Year Ending December 31, 2025 - MarketScreener

Aug 07, 2025

Zimmer Biomet Holdings Inc Stock (ZBH) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Zimmer Biomet Holdings Inc Stock (ZBH) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Yi Sang
Group President, Asia Pacific
Jun 13 '25
Sale
92.51
800
74,011
19,624
Yi Sang
Group President, Asia Pacific
Jun 11 '25
Sale
95.00
1,000
95,000
20,424
$304.84
price down icon 0.74%
medical_devices STE
$241.62
price down icon 0.51%
medical_devices PHG
$26.68
price down icon 0.60%
$77.85
price down icon 1.28%
$73.00
price up icon 1.39%
medical_devices EW
$78.16
price down icon 0.24%
Cap:     |  Volume (24h):